Akèy › Polimiyozit
Etid klinik pou Polimiyozit ap rekrite nan Etazini
12 etid pou Polimiyozit ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
Pa eta
- Arizona3 etid
- Kalifòni4 etid
- Maryland4 etid
- Massachusetts3 etid
- New York3 etid
- North Carolina5 etid
- Texas3 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Environmental Risk Factors for the Anti-synthetase Syndrome
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 2 a 100 · Tout sèks · Mizajou Sep 28, 2026 · NCT01276470Natural History of Inflammatory Muscle Diseases
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 2 a 120 · Tout sèks · Mizajou Sep 24, 2026 · NCT05738824Adult and Juvenile Myositis
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 2 a 100 · Tout sèks · Mizajou Sep 24, 2026 · NCT00017914A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Sep 24, 2026 · NCT06455449A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
Ap rekriteFaz 1
Laj 18 a 70 · Tout sèks · Mizajou Sep 15, 2026 · NCT06916806A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT05895786FT839 in Autoimmune Diseases
Ap rekriteFaz 1/2
Laj 18 a 70 · Tout sèks · Mizajou Sep 2, 2026 · NCT07800871A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT06698796A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jul 14, 2026 · NCT07115745Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 9, 2026 · NCT07138898Rheumatology Patient Registry and Biorepository
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 99 · Tout sèks · Mizajou Feb 13, 2026 · NCT04402086MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)
Ap rekriteEtid obsèvasyon
Laj 7 ak plis · Tout sèks · Mizajou Jan 28, 2026 · NCT07374107Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.